Peroperative administration of tranexamic acid in sleeve gastrectomy

Peroperative Administration of Tranexamic Acid in Sleeve gastrectomy (PATAS) to reduce hemorrhage rates

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28904

Enrollment

100

Registered

2019-04-19

Start date

2020-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity

Interventions

Administration of tranexamic acid versus placebo

Eligibility

Inclusion criteria

Inclusion criteria: Primary bariatric procedure; good command of the Dutch or English language

Exclusion criteria

Exclusion criteria: Patients unwilling to give informed consent, patients with a medical history of bleeding or VTE and patients who use therapeutic anticoagulants. Patients will also be excluded in case of peroperative arterial bleeding or (iatrogenic) bleeding coming from surrounding organs or vascular structures.

Design outcomes

Primary

Measure	Time frame
peroperative use of hemostatic staples, the decrease in hemoglobin after the procedure and reoperation rates of postoperative hemorrhage	—

Secondary

Measure	Time frame
rates of deep venous thrombosis (DVT) and pulmonary embolism (PE)	—

Contacts

Public ContactJudith 't Hart

Franciscus Gasthuis & Vlietland

j.hart@franciscus.nl0031104616161

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)